Status:

COMPLETED

Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes

Lead Sponsor:

Medical University of Graz

Collaborating Sponsors:

European Commission

Conditions:

Type 1 Diabetes

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

Brief Summary

Rationale: For the development of a closed loop system, faster insulin absorption after bolus administration could help to reduce the system's delay and thus increase patient safety. It has been shown...

Eligibility Criteria

Inclusion

  • Informed consent obtained after being advised of the nature of the study
  • Male or female aged 18-60 years (both inclusive)
  • Type 1 diabetes treated with multiple daily insulin injection or continuous subcutaneous insulin infusion for 12 months
  • Fasting C-peptide \< 0.3nmol/L
  • Body mass index 20.0-28.0 kg/m² (both inclusive)
  • HbA1c \< 10%

Exclusion

  • Female of childbearing potential who is pregnant, breast-feeding or intend to become pregnant or is not using adequate contraceptive methods
  • Skin pathology or condition prohibiting needle insertion/insulin administration as judged by the investigator
  • History of bleeding disorder
  • Current participation in another clinical study
  • Significant acute or chronic illness that might interfere with subject safety or integrity of results as judged by the investigator
  • Smoker (defined as \>5 cigarettes/d)
  • Lipodystrophy
  • Current treatment with systemic (oral or i.v.) corticosteroids, monoamine oxidase (MAO) inhibitors, non-selective beta-blockers, growth hormone, herbal products or non-routine vitamins. Furthermore, thyroid hormones are not allowed unless the use of these has been stable during the past 3 months.
  • Significant history of alcoholism or drug abuse or a positive result in urine drug/alcohol screen.
  • Study Day

Key Trial Info

Start Date :

April 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2011

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT01399346

Start Date

April 1 2011

End Date

June 1 2011

Last Update

April 20 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University of Graz

Graz, Austria, 8036